18 June 2025
FDI Screening in the EU: Member States adopt common negotiating position on revisions to the EU’s Foreign Direct Investment Screening Regulation
1 min read
On 11 June 2025, the Council of the European Union adopted a mandate for negotiations with the European Parliament and the European Commission regarding the proposal for a Regulation on the screening of foreign investments in the Union and repealing Regulation (EU) 2019/452.
On 11 June 2025, the Council of the European Union (the Council) adopted a mandate for negotiations (the Mandate) with the European Parliament (the Parliament) and the European Commission (the Commission) regarding the proposal for a Regulation on the screening of foreign investments in the Union and repealing Regulation (EU) 2019/452 (the Proposed Revised FDI Regulation).
Our latest Client Alert below explores more.
Attachments:
->
News & insights
1 min
read
read
Briefings
VBB secures lowest anti-dumping duty for Hankook in EU passenger car tyre investigation
7 July 2026
2 min
read
read
Briefings
Lithuanian Competition Authority Fines Pharmacy Association and Individual Firms for Collusion while Participating in Margin-setting Procedure
14 December 2022
2 min
read
read
Briefings
France - Supreme Court Allows Follow-on Damages Action by Health Insurer in Wake of Sanofi’s Denigration Strategy against Generic Rivals
13 October 2023
2 min
read
read
Briefings
European Commission Sends Statement of Objections to Teva over Abusive Patent Filings and Disparagement of Generic Competitors
11 October 2022
1 min
read
read
Briefings
F. Hoffmann-La Roche and Novartis (Avastin - Lucentis) – ECJ Finds Concerted Efforts to Restrict Off-label Use of Medicinal Products Likely to Breach Competition Rules
24 January 2018
3 min
read
read
Briefings
Advocate General Recommends to Court of Justice of European Union to Allow Reimbursement of Off Label Use of Medicine for Purely Budgetary Reasons
30 August 2018
3 min
read
read
Briefings
“National Healthcare Insurance Systems Are Allowed To Reimburse Off-Label Use of Medicine” Says ECJ
21 November 2018
3 min
read
read
Briefings
French Competition Authority - Genentech, Novartis and Roche Fined EUR 444 million in Saga Involving Wet Age-Related Macular Degeneration
9 September 2020
